Blood Collection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Collection Site (Venous {Needles and Syringes, Blood collection Tubes, Blood Bags, Others}, Capillary {Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices, Others}), By Application (Diagnostics, Treatment), By Method (Manual, Automated), By End-use (Hospitals, Blood Banks, Others), By Region and Competition, 2019-2029F
Global Blood Collection Market was valued at USD 9.26 billion in 2023 and is anticipated t%li%project impressive growth in the forecast period with a CAGR of 6.07% through 2029. Blood collection is a crucial component of the healthcare infrastructure, supporting medical treatments, surgeries, trauma care, and disease management. Blood collection involves the voluntary donation or medical extraction of blood from donors. Once collected, the blood undergoes meticulous testing t%li%ensure its safety and compatibility for transfusion. This process is essential for addressing a range of medical scenarios, from surgeries and trauma care t%li%managing chronic conditions and cancer treatments. The blood collection market encompasses a wide range of activities, including blood donation, processing, testing, across the globe. Blood collection includes voluntary blood donations from individuals wh%li%are willing t%li%donate their blood t%li%help others in need. These donors can be individuals or organized groups, and they contribute either storage, and distribution. Patients with chronic disorders are treated using blood collection products, notably during difficult surgeries, dialysis, chemotherapy, and organ or tissue transplant operations. Surgeries, both routine and complex, often require blood transfusions t%li%replace blood loss, ensure oxygen transport, and support the body's healing process. Blood collection centers provide the necessary supply for such interventions. The blood collection market is highly influenced by the rise in blood donations whole blood or specific blood components such as red blood cells, platelets, plasma, etc. The blood collection industry is highly regulated by national and international health authorities t%li%ensure the safety and quality of blood and blood products. Regulatory frameworks cover donor eligibility criteria, testing standards, storage conditions, labeling, and transportation.
Key Market Drivers
Growing Demand of Blood in Increasing Chronic Disease Prevalence
The global blood collection market is witnessing a substantial surge in demand, driven significantly by the increasing prevalence of chronic diseases across the globe. Chronic diseases, characterized by their long-lasting and often progressive nature, encompass a wide range of conditions such as cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases. This escalating burden of chronic diseases has a direct and profound impact on the demand for blood collection services and products. According t%li%the World Health Organization (WHO), chronic diseases are the leading cause of mortality worldwide, accounting for approximately 71% of all deaths. The prevalence of chronic diseases is accelerating due t%li%factors like aging populations, urbanization, unhealthy lifestyles, and genetic predisposition. The toll of chronic diseases is felt across all age groups and regions, making their effective management a critical healthcare priority. Many chronic diseases necessitate medical interventions that require blood transfusions. Surgeries, chemotherapy, radiation therapy, and interventions t%li%manage complications often rely on a consistent supply of blood products. Certain chronic diseases, such as anemia in chronic kidney disease or leukemia in cancer patients, can lead t%li%blood-related disorders. These disorders often require regular blood transfusions t%li%manage symptoms and improve patients' quality of life. Chronic diseases can lead t%li%unexpected complications that require emergency interventions, often involving blood transfusions.
Surge in Medical Interventions
Medical advancements have propelled the healthcare industry int%li%new realms of precision and effectiveness. With a rising number of intricate medical interventions being performed worldwide, the demand for blood collection has soared t%li%unprecedented heights. This symbiotic relationship between medical procedures and blood collection plays a pivotal role in ensuring successful outcomes for patients across various medical domains. The increasing prevalence of complex surgeries, organ transplants, and advanced treatments for conditions such as cancer and cardiovascular diseases has given rise t%li%a greater need for blood collection. Blood, a vital source of life-sustaining components, serves multiple functions in modern healthcare. From providing oxygen and nutrients t%li%tissues t%li%facilitating the immune response, blood is an irreplaceable resource. Consequently, medical interventions that involve blood loss necessitate replenishing this crucial fluid t%li%maintain patients' stability and recovery. Transfusions, a key component of medical care, rely heavily on blood collection. Patients undergoing surgeries, particularly those that involve extensive tissue manipulation, require blood transfusions t%li%compensate for blood loss and optimize their chances of recovery. Similarly, individuals undergoing chemotherapy or radiation therapy often experience decreased red blood cell counts, prompting the need for blood transfusions t%li%alleviate anemia and its associated symptoms. Emerging medical fields such as regenerative medicine and gene therapy are als%li%contributing t%li%the surge in blood collection demands. Stem cell transplants, a cornerstone of regenerative medicine, require donors and recipients t%li%underg%li%thorough blood compatibility testing. Similarly, gene therapy, which holds promising potential in treating genetic disorders, requires meticulous monitoring of patients' blood parameters t%li%ensure the effectiveness and safety of the treatment. As the demand for blood collection continues t%li%rise, the importance of efficient blood management cannot be overstated. Blood banks and donation centers play a pivotal role in ensuring a steady supply of safe and compatible blood products. Additionally, advancements in blood storage and preservation techniques have extended the shelf life of collected blood, allowing healthcare providers more flexibility in managing their inventory.
Rising Technological Innovations
In healthcare, technological innovations have emerged as a significant driver behind the increased demand for blood collection. These innovations, ranging from advanced medical procedures t%li%cutting-edge diagnostic tools, have reshaped the way medical interventions are performed and consequently amplified the necessity for efficient blood collection. One significant technological advancement that has bolstered the demand for blood collection is the rise of minimally invasive surgeries. Procedures once requiring large incisions have been replaced by less intrusive techniques, resulting in reduced patient trauma and quicker recovery times. However, these minimally invasive surgeries can still lead t%li%blood loss, albeit on a smaller scale. Consequently, the demand for blood collection, even in these less invasive procedures, remains crucial t%li%ensure patients' well-being during and after surgery. Additionally, diagnostic technologies have als%li%played a pivotal role in increasing blood collection demand. The advent of precision medicine and personalized diagnostics has led t%li%a greater emphasis on early disease detection and targeted treatments. Biomarker analysis, which often involves blood testing, provides valuable insights int%li%a patient's health status and aids in tailoring treatment plans. As a result, the need for blood collection t%li%facilitate these diagnostic endeavors has grown significantly. The development of advanced treatments such as immunotherapies and gene therapies has further propelled the demand for blood collection. These revolutionary treatments require comprehensive patient profiling and ongoing monitoring of blood parameters t%li%ensure their effectiveness and safety. Blood samples offer valuable information about a patient's immune response, genetic makeup, and overall health, making them indispensable in the management of these novel therapeutic approaches. Telemedicine and remote patient monitoring have als%li%contributed t%li%the surge in blood collection demand. With the ability t%li%remotely track patients' health conditions, healthcare providers can identify potential issues early on and initiate appropriate interventions. Blood samples collected at local clinics or even at patients' homes can be swiftly analyzed, allowing for timely adjustments t%li%treatment plans.
Key Market Challenges
Sustaining Adequate Supply
Ensuring a consistent and sufficient supply of blood remains a paramount challenge for the global blood collection industry. Factors such as seasonal variations, emergencies, and evolving donor demographics can lead t%li%periodic shortages. The industry grapples with fluctuating supplies caused by factors like seasonal shifts and unforeseen emergencies. These variations can result in periodic shortages, straining the availability of critical blood products. Ensuring a reliable supply chain that can swiftly adapt t%li%these dynamics remains a significant challenge, demanding proactive strategies t%li%anticipate and address shortages promptly. Encouraging regular voluntary donations, particularly in regions with cultural or logistical barriers, poses a constant challenge. Maintaining a diverse and committed donor pool t%li%meet the diverse needs of patients and medical procedures requires ongoing efforts and innovative strategies.
Safety and Testing Assurance
Maintaining the safety and quality of donated blood is a critical challenge. Stringent testing protocols are essential t%li%identify infectious agents and ensure compatibility. However, new pathogens and emerging diseases continuously pose challenges t%li%existing testing methods. Striking a balance between stringent testing procedures and the urgent need for timely availability is a complex challenge. Emerging diseases and the appearance of previously unidentified infectious agents necessitate constant vigilance. The adaptability of these pathogens calls for a dynamic approach t%li%testing and safety measures. Blood collection centers must remain agile, prepared t%li%integrate new testing technologies and protocols t%li%effectively screen for these emerging threats. Ensuring donor and recipient safety while mitigating the risk of transmitting infections remains a constant focus for blood collection centers worldwide. Implementing stringent protocols, updating practices in response t%li%emerging threats, and fostering a culture of awareness among donors and staff are pivotal.
Logistics and Distribution Efficiency
Efficient transportation and distribution networks are essential t%li%deliver blood products promptly t%li%medical facilities. However, logistical challenges such as transportation delays, infrastructure limitations, and remote area accessibility hinder timely distribution. Maintaining temperature-controlled conditions t%li%preserve the quality of blood products during transit presents logistical complexities. Maintaining temperature-controlled conditions throughout the journey is paramount t%li%safeguarding the viability and integrity of blood components. Coordinating with multiple stakeholders, including blood banks, hospitals, and transportation providers, requires meticulous planning and continuous monitoring t%li%optimize distribution efficiency. Continuous monitoring, tracking, and analysis of distribution processes are necessary t%li%identify loopholes, enhance performance, and respond t%li%unforeseen challenges. The optimization of distribution efficiency demands a proactive approach that relies on real-time data and feedback loops.
Key Market Trends
Sustainable and Eco-Friendly Solutions
Advances in genomics and personalized medicine are tailoring healthcare treatments t%li%individual patients. This trend is extending t%li%blood collection, with a focus on providing blood products that match patients' genetic profiles. Precise compatibility reduces the risk of adverse reactions, making personalized blood products an emerging area of growth. This transformative trend is not only revolutionizing treatment approaches but is als%li%extending its influence on the blood collection sector. By leveraging genetic insights, blood collection is venturing int%li%a realm of precision by offering blood products that align with individual patients' genetic profiles. This innovative approach is poised t%li%redefine compatibility, safety, and patient outcomes in the realm of blood transfusions. Advances in genomics now allow for a deeper understanding of a patient's genetic makeup, paving the way for more precise compatibility assessments. By analyzing specific genetic markers related t%li%blood compatibility, personalized blood products can be tailored t%li%match the recipient's unique genetic profile. This targeted approach greatly reduces the risk of adverse reactions, ensuring a safer and more effective transfusion process. Adverse reactions t%li%blood transfusions can range from mild discomfort t%li%life-threatening complications. With personalized blood products, the risk of immune reactions, such as hemolytic transfusion reactions, can be significantly minimized. By aligning the genetic compatibility of donor and recipient, the likelihood of negative responses is greatly reduced, ultimately enhancing patient safety, and improving overall outcomes. The integration of genomics int%li%blood collection is pioneering a new era where customization and precision are paramount. Laboratories equipped with advanced genetic testing capabilities can analyze the genetic markers that determine blood compatibility. This information is then used t%li%match donors with recipients in a way that minimizes the potential for incompatibility-related complications.
Segmental Insights
Collection Site Insights
In 2023, the blood collection market was dominated by the venous segment and accounted for largest share in the market and is anticipated t%li%continue expanding over the coming years. The primary factors influencing the growth of the venous segment are the rise in the demand for medical equipment for detection and diagnosis as well as the number of surgical procedures. The market is als%li%rising as a result of increased knowledge of the benefits of venous blood collection devices over alternative techniques. The major advantage of these devices is that they are comparably painless and just need a minimal amount of blood for the treatment. Due t%li%factors including the lower blood samples requirement, which reduces the danger of contamination, along with the rising research & development t%li%create a wide range of innovative products, the capillary segment is predicted t%li%experience the quickest growth rate during the forecast period.
End-Use Insights
In 2023, the blood collection market has seen the dominance of the hospitals segment, and this trend is expected t%li%persist and even expand in the foreseeable future. Hospitals have historically been the primary locations for blood collection activities due t%li%their central role in healthcare delivery and their ability t%li%handle a wide range of medical procedures. As the prevalence of chronic diseases continues t%li%rise globally, there is a corresponding increase in the demand for diagnostic and screening procedures, which further drives the need for blood collection services within hospital settings. Advancements in blood collection technology have led t%li%improved efficiency, safety, and patient comfort, making it more convenient for hospitals t%li%collect and process blood samples. This includes the development of innovative devices and techniques for venipuncture, as well as the implementation of automated systems for sample handling and processing.
The growing demand for blood products, such as red blood cells, platelets, and plasma, is driving hospitals t%li%expand their blood collection capabilities. Blood transfusions are essential for various medical treatments, including surgeries, trauma care, cancer therapy, and organ transplants. Therefore, hospitals need t%li%maintain adequate stocks of blood products t%li%meet the needs of their patients, leading t%li%increased collection efforts. Changing regulatory requirements pertaining t%li%blood safety and quality assurance als%li%play a significant role in shaping the hospitals segment of the blood collection market. Healthcare authorities worldwide impose strict regulations t%li%ensure the safety and integrity of blood products, including screening for infectious diseases and proper handling procedures. Hospitals must comply with these regulations, which often necessitate investments in infrastructure, staff training, and quality control measures.
Regional Insights
The North America region has emerged as the frontrunner in the Global Blood Collection Market, solidifying its position through various factors contributing t%li%its sustained growth and dominance. One of the primary drivers fueling this market supremacy is the surge in traffic accidents and the prevalence of chronic diseases across the region. The incidence of traffic accidents in North America has been on the rise in recent years, resulting in a greater demand for blood collection products and services. Traumatic injuries sustained in accidents often necessitate immediate blood transfusions t%li%save lives, thereby driving the need for efficient blood collection and storage systems. The region's aging population, coupled with lifestyle factors, has led t%li%an increased prevalence of chronic diseases such as cardiovascular disorders, cancer, and diabetes. These conditions often require regular blood tests and monitoring, further contributing t%li%the demand for blood collection services.
North America boasts a robust healthcare infrastructure with advanced medical facilities and well-established blood collection centers. The presence of state-of-the-art laboratories equipped with cutting-edge technologies facilitates efficient blood collection, processing, and storage procedures. Additionally, the region is home t%li%several leading players in the blood collection market, fostering a competitive landscape and driving innovation in product development and service offerings. Government initiatives and healthcare policies als%li%play a significant role in shaping the blood collection market in North America. Regulatory bodies such as the Food and Drug Administration (FDA) ensure adherence t%li%stringent quality standards and safety regulations, instilling confidence among consumers and healthcare providers alike. Government-sponsored initiatives aimed at increasing awareness about blood donation and promoting voluntary donation drives contribute t%li%the availability of blood products for medical purposes.
Key Market Players
In this report, the Global Blood Collection Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Blood Collection Market.
Available Customizations:
Global Blood Collection Market report with the given market data, Tech Sci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
Growing Demand of Blood in Increasing Chronic Disease Prevalence
The global blood collection market is witnessing a substantial surge in demand, driven significantly by the increasing prevalence of chronic diseases across the globe. Chronic diseases, characterized by their long-lasting and often progressive nature, encompass a wide range of conditions such as cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases. This escalating burden of chronic diseases has a direct and profound impact on the demand for blood collection services and products. According t%li%the World Health Organization (WHO), chronic diseases are the leading cause of mortality worldwide, accounting for approximately 71% of all deaths. The prevalence of chronic diseases is accelerating due t%li%factors like aging populations, urbanization, unhealthy lifestyles, and genetic predisposition. The toll of chronic diseases is felt across all age groups and regions, making their effective management a critical healthcare priority. Many chronic diseases necessitate medical interventions that require blood transfusions. Surgeries, chemotherapy, radiation therapy, and interventions t%li%manage complications often rely on a consistent supply of blood products. Certain chronic diseases, such as anemia in chronic kidney disease or leukemia in cancer patients, can lead t%li%blood-related disorders. These disorders often require regular blood transfusions t%li%manage symptoms and improve patients' quality of life. Chronic diseases can lead t%li%unexpected complications that require emergency interventions, often involving blood transfusions.
Surge in Medical Interventions
Medical advancements have propelled the healthcare industry int%li%new realms of precision and effectiveness. With a rising number of intricate medical interventions being performed worldwide, the demand for blood collection has soared t%li%unprecedented heights. This symbiotic relationship between medical procedures and blood collection plays a pivotal role in ensuring successful outcomes for patients across various medical domains. The increasing prevalence of complex surgeries, organ transplants, and advanced treatments for conditions such as cancer and cardiovascular diseases has given rise t%li%a greater need for blood collection. Blood, a vital source of life-sustaining components, serves multiple functions in modern healthcare. From providing oxygen and nutrients t%li%tissues t%li%facilitating the immune response, blood is an irreplaceable resource. Consequently, medical interventions that involve blood loss necessitate replenishing this crucial fluid t%li%maintain patients' stability and recovery. Transfusions, a key component of medical care, rely heavily on blood collection. Patients undergoing surgeries, particularly those that involve extensive tissue manipulation, require blood transfusions t%li%compensate for blood loss and optimize their chances of recovery. Similarly, individuals undergoing chemotherapy or radiation therapy often experience decreased red blood cell counts, prompting the need for blood transfusions t%li%alleviate anemia and its associated symptoms. Emerging medical fields such as regenerative medicine and gene therapy are als%li%contributing t%li%the surge in blood collection demands. Stem cell transplants, a cornerstone of regenerative medicine, require donors and recipients t%li%underg%li%thorough blood compatibility testing. Similarly, gene therapy, which holds promising potential in treating genetic disorders, requires meticulous monitoring of patients' blood parameters t%li%ensure the effectiveness and safety of the treatment. As the demand for blood collection continues t%li%rise, the importance of efficient blood management cannot be overstated. Blood banks and donation centers play a pivotal role in ensuring a steady supply of safe and compatible blood products. Additionally, advancements in blood storage and preservation techniques have extended the shelf life of collected blood, allowing healthcare providers more flexibility in managing their inventory.
Rising Technological Innovations
In healthcare, technological innovations have emerged as a significant driver behind the increased demand for blood collection. These innovations, ranging from advanced medical procedures t%li%cutting-edge diagnostic tools, have reshaped the way medical interventions are performed and consequently amplified the necessity for efficient blood collection. One significant technological advancement that has bolstered the demand for blood collection is the rise of minimally invasive surgeries. Procedures once requiring large incisions have been replaced by less intrusive techniques, resulting in reduced patient trauma and quicker recovery times. However, these minimally invasive surgeries can still lead t%li%blood loss, albeit on a smaller scale. Consequently, the demand for blood collection, even in these less invasive procedures, remains crucial t%li%ensure patients' well-being during and after surgery. Additionally, diagnostic technologies have als%li%played a pivotal role in increasing blood collection demand. The advent of precision medicine and personalized diagnostics has led t%li%a greater emphasis on early disease detection and targeted treatments. Biomarker analysis, which often involves blood testing, provides valuable insights int%li%a patient's health status and aids in tailoring treatment plans. As a result, the need for blood collection t%li%facilitate these diagnostic endeavors has grown significantly. The development of advanced treatments such as immunotherapies and gene therapies has further propelled the demand for blood collection. These revolutionary treatments require comprehensive patient profiling and ongoing monitoring of blood parameters t%li%ensure their effectiveness and safety. Blood samples offer valuable information about a patient's immune response, genetic makeup, and overall health, making them indispensable in the management of these novel therapeutic approaches. Telemedicine and remote patient monitoring have als%li%contributed t%li%the surge in blood collection demand. With the ability t%li%remotely track patients' health conditions, healthcare providers can identify potential issues early on and initiate appropriate interventions. Blood samples collected at local clinics or even at patients' homes can be swiftly analyzed, allowing for timely adjustments t%li%treatment plans.
Key Market Challenges
Sustaining Adequate Supply
Ensuring a consistent and sufficient supply of blood remains a paramount challenge for the global blood collection industry. Factors such as seasonal variations, emergencies, and evolving donor demographics can lead t%li%periodic shortages. The industry grapples with fluctuating supplies caused by factors like seasonal shifts and unforeseen emergencies. These variations can result in periodic shortages, straining the availability of critical blood products. Ensuring a reliable supply chain that can swiftly adapt t%li%these dynamics remains a significant challenge, demanding proactive strategies t%li%anticipate and address shortages promptly. Encouraging regular voluntary donations, particularly in regions with cultural or logistical barriers, poses a constant challenge. Maintaining a diverse and committed donor pool t%li%meet the diverse needs of patients and medical procedures requires ongoing efforts and innovative strategies.
Safety and Testing Assurance
Maintaining the safety and quality of donated blood is a critical challenge. Stringent testing protocols are essential t%li%identify infectious agents and ensure compatibility. However, new pathogens and emerging diseases continuously pose challenges t%li%existing testing methods. Striking a balance between stringent testing procedures and the urgent need for timely availability is a complex challenge. Emerging diseases and the appearance of previously unidentified infectious agents necessitate constant vigilance. The adaptability of these pathogens calls for a dynamic approach t%li%testing and safety measures. Blood collection centers must remain agile, prepared t%li%integrate new testing technologies and protocols t%li%effectively screen for these emerging threats. Ensuring donor and recipient safety while mitigating the risk of transmitting infections remains a constant focus for blood collection centers worldwide. Implementing stringent protocols, updating practices in response t%li%emerging threats, and fostering a culture of awareness among donors and staff are pivotal.
Logistics and Distribution Efficiency
Efficient transportation and distribution networks are essential t%li%deliver blood products promptly t%li%medical facilities. However, logistical challenges such as transportation delays, infrastructure limitations, and remote area accessibility hinder timely distribution. Maintaining temperature-controlled conditions t%li%preserve the quality of blood products during transit presents logistical complexities. Maintaining temperature-controlled conditions throughout the journey is paramount t%li%safeguarding the viability and integrity of blood components. Coordinating with multiple stakeholders, including blood banks, hospitals, and transportation providers, requires meticulous planning and continuous monitoring t%li%optimize distribution efficiency. Continuous monitoring, tracking, and analysis of distribution processes are necessary t%li%identify loopholes, enhance performance, and respond t%li%unforeseen challenges. The optimization of distribution efficiency demands a proactive approach that relies on real-time data and feedback loops.
Key Market Trends
Sustainable and Eco-Friendly Solutions
Advances in genomics and personalized medicine are tailoring healthcare treatments t%li%individual patients. This trend is extending t%li%blood collection, with a focus on providing blood products that match patients' genetic profiles. Precise compatibility reduces the risk of adverse reactions, making personalized blood products an emerging area of growth. This transformative trend is not only revolutionizing treatment approaches but is als%li%extending its influence on the blood collection sector. By leveraging genetic insights, blood collection is venturing int%li%a realm of precision by offering blood products that align with individual patients' genetic profiles. This innovative approach is poised t%li%redefine compatibility, safety, and patient outcomes in the realm of blood transfusions. Advances in genomics now allow for a deeper understanding of a patient's genetic makeup, paving the way for more precise compatibility assessments. By analyzing specific genetic markers related t%li%blood compatibility, personalized blood products can be tailored t%li%match the recipient's unique genetic profile. This targeted approach greatly reduces the risk of adverse reactions, ensuring a safer and more effective transfusion process. Adverse reactions t%li%blood transfusions can range from mild discomfort t%li%life-threatening complications. With personalized blood products, the risk of immune reactions, such as hemolytic transfusion reactions, can be significantly minimized. By aligning the genetic compatibility of donor and recipient, the likelihood of negative responses is greatly reduced, ultimately enhancing patient safety, and improving overall outcomes. The integration of genomics int%li%blood collection is pioneering a new era where customization and precision are paramount. Laboratories equipped with advanced genetic testing capabilities can analyze the genetic markers that determine blood compatibility. This information is then used t%li%match donors with recipients in a way that minimizes the potential for incompatibility-related complications.
Segmental Insights
Collection Site Insights
In 2023, the blood collection market was dominated by the venous segment and accounted for largest share in the market and is anticipated t%li%continue expanding over the coming years. The primary factors influencing the growth of the venous segment are the rise in the demand for medical equipment for detection and diagnosis as well as the number of surgical procedures. The market is als%li%rising as a result of increased knowledge of the benefits of venous blood collection devices over alternative techniques. The major advantage of these devices is that they are comparably painless and just need a minimal amount of blood for the treatment. Due t%li%factors including the lower blood samples requirement, which reduces the danger of contamination, along with the rising research & development t%li%create a wide range of innovative products, the capillary segment is predicted t%li%experience the quickest growth rate during the forecast period.
End-Use Insights
In 2023, the blood collection market has seen the dominance of the hospitals segment, and this trend is expected t%li%persist and even expand in the foreseeable future. Hospitals have historically been the primary locations for blood collection activities due t%li%their central role in healthcare delivery and their ability t%li%handle a wide range of medical procedures. As the prevalence of chronic diseases continues t%li%rise globally, there is a corresponding increase in the demand for diagnostic and screening procedures, which further drives the need for blood collection services within hospital settings. Advancements in blood collection technology have led t%li%improved efficiency, safety, and patient comfort, making it more convenient for hospitals t%li%collect and process blood samples. This includes the development of innovative devices and techniques for venipuncture, as well as the implementation of automated systems for sample handling and processing.
The growing demand for blood products, such as red blood cells, platelets, and plasma, is driving hospitals t%li%expand their blood collection capabilities. Blood transfusions are essential for various medical treatments, including surgeries, trauma care, cancer therapy, and organ transplants. Therefore, hospitals need t%li%maintain adequate stocks of blood products t%li%meet the needs of their patients, leading t%li%increased collection efforts. Changing regulatory requirements pertaining t%li%blood safety and quality assurance als%li%play a significant role in shaping the hospitals segment of the blood collection market. Healthcare authorities worldwide impose strict regulations t%li%ensure the safety and integrity of blood products, including screening for infectious diseases and proper handling procedures. Hospitals must comply with these regulations, which often necessitate investments in infrastructure, staff training, and quality control measures.
Regional Insights
The North America region has emerged as the frontrunner in the Global Blood Collection Market, solidifying its position through various factors contributing t%li%its sustained growth and dominance. One of the primary drivers fueling this market supremacy is the surge in traffic accidents and the prevalence of chronic diseases across the region. The incidence of traffic accidents in North America has been on the rise in recent years, resulting in a greater demand for blood collection products and services. Traumatic injuries sustained in accidents often necessitate immediate blood transfusions t%li%save lives, thereby driving the need for efficient blood collection and storage systems. The region's aging population, coupled with lifestyle factors, has led t%li%an increased prevalence of chronic diseases such as cardiovascular disorders, cancer, and diabetes. These conditions often require regular blood tests and monitoring, further contributing t%li%the demand for blood collection services.
North America boasts a robust healthcare infrastructure with advanced medical facilities and well-established blood collection centers. The presence of state-of-the-art laboratories equipped with cutting-edge technologies facilitates efficient blood collection, processing, and storage procedures. Additionally, the region is home t%li%several leading players in the blood collection market, fostering a competitive landscape and driving innovation in product development and service offerings. Government initiatives and healthcare policies als%li%play a significant role in shaping the blood collection market in North America. Regulatory bodies such as the Food and Drug Administration (FDA) ensure adherence t%li%stringent quality standards and safety regulations, instilling confidence among consumers and healthcare providers alike. Government-sponsored initiatives aimed at increasing awareness about blood donation and promoting voluntary donation drives contribute t%li%the availability of blood products for medical purposes.
Key Market Players
- NIPRO Medical Corporation
- Abbott Laboratories Inc.
- Becton, Dickinson and Company
- Terum%li%Corporation
- Qiagen N.V
- Medtronic plc
- FL Medical s.r.l.
- SARSTEDT AG & Co. KG
- Greiner Holding AG
- Haemonetics Corporation
In this report, the Global Blood Collection Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- Blood Collection Market, By Collection Site:
- Venous
- Needles & Syringes
- Blood collection Tubes
- Blood Bags
- Others
- Capillary
- Lancets
- Micro-Container Tubes
- Micro-Hematocrit Tubes
- Warming Devices
- Others
- Blood Collection Market, By Application:
- Diagnostics
- Treatment
- Blood Collection Market, By Method:
- Manual
- Automated
- Blood Collection Market, By End-use:
- Hospitals
- Blood Banks
- Others
- Blood Collection Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
- Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Blood Collection Market.
Available Customizations:
Global Blood Collection Market report with the given market data, Tech Sci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL BLOOD COLLECTION MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Collection Site (Venous {Needles and Syringes, Blood collection Tubes, Blood Bags, Others}, Capillary {Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices, Others})
5.2.2. By Application (Diagnostics, Treatment)
5.2.3. By Method (Manual, Automated)
5.2.4. By End-use (Hospitals, Blood Banks, Others)
5.2.5. By Company (2023)
5.2.6. By Region
5.3. Market Map
6. NORTH AMERICA BLOOD COLLECTION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Collection Site
6.2.2. By Application
6.2.3. By Method
6.2.4. By End-use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Blood Collection Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Collection Site
6.3.1.2.2. By Application
6.3.1.2.3. By Method
6.3.1.2.4. By End Use
6.3.2. Mexico Blood Collection Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Collection Site
6.3.2.2.2. By Application
6.3.2.2.3. By Method
6.3.2.2.4. By End Use
6.3.3. Canada Blood Collection Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Collection Site
6.3.3.2.2. By Application
6.3.3.2.3. By Method
6.3.3.2.4. By End Use
7. EUROPE BLOOD COLLECTION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Collection Site
7.2.2. By Application
7.2.3. By Method
7.2.4. By End-use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Blood Collection Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Collection Site
7.3.1.2.2. By Application
7.3.1.2.3. By Method
7.3.1.2.4. By End Use
7.3.2. Germany Blood Collection Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Collection Site
7.3.2.2.2. By Application
7.3.2.2.3. By Method
7.3.2.2.4. By End Use
7.3.3. United Kingdom Blood Collection Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Collection Site
7.3.3.2.2. By Application
7.3.3.2.3. By Method
7.3.3.2.4. By End Use
7.3.4. Italy Blood Collection Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Collection Site
7.3.4.2.2. By Application
7.3.4.2.3. By Method
7.3.4.2.4. By End Use
7.3.5. Spain Blood Collection Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Collection Site
7.3.5.2.2. By Application
7.3.5.2.3. By Method
7.3.5.2.4. By End Use
8. ASIA-PACIFIC BLOOD COLLECTION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Collection Site
8.2.2. By Application
8.2.3. By Method
8.2.4. By End-use
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Blood Collection Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Collection Site
8.3.1.2.2. By Application
8.3.1.2.3. By Method
8.3.1.2.4. By End Use
8.3.2. India Blood Collection Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Collection Site
8.3.2.2.2. By Application
8.3.2.2.3. By Method
8.3.2.2.4. By End Use
8.3.3. South Korea Blood Collection Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Collection Site
8.3.3.2.2. By Application
8.3.3.2.3. By Method
8.3.3.2.4. By End Use
8.3.4. Japan Blood Collection Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Collection Site
8.3.4.2.2. By Application
8.3.4.2.3. By Method
8.3.4.2.4. By End Use
8.3.5. Australia Blood Collection Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Collection Site
8.3.5.2.2. By Application
8.3.5.2.3. By Method
8.3.5.2.4. By End Use
9. SOUTH AMERICA BLOOD COLLECTION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Collection Market Site
9.2.2. By Application
9.2.3. By Method
9.2.4. By End-use
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Blood Collection Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Collection Site
9.3.1.2.2. By Application
9.3.1.2.3. By Method
9.3.1.2.4. By End Use
9.3.2. Argentina Blood Collection Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Collection Site
9.3.2.2.2. By Application
9.3.2.2.3. By Method
9.3.2.2.4. By End Use
9.3.3. Colombia Blood Collection Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Collection Site
9.3.3.2.2. By Application
9.3.3.2.3. By Method
9.3.3.2.4. By End Use
10. MIDDLE EAST AND AFRICA BLOOD COLLECTION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Collection Market Site
10.2.2. By Application
10.2.3. By Method
10.2.4. By End-use
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Blood Collection Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Collection Site
10.3.1.2.2. By Application
10.3.1.2.3. By Method
10.3.1.2.4. By End Use
10.3.2. Saudi Arabia Blood Collection Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Collection Site
10.3.2.2.2. By Application
10.3.2.2.3. By Method
10.3.2.2.4. By End Use
10.3.3. UAE Blood Collection Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Collection Site
10.3.3.2.2. By Application
10.3.3.2.3. By Method
10.3.3.2.4. By End Use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. COMPETITIVE LANDSCAPE
15.1. NIPRO Medical Corporation
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Abbott Laboratories Inc.
15.3. Becton, Dickinson and Company
15.4. Terumo Corporation
15.5. Qiagen N.V
15.6. Medtronic plc
15.7. FL Medical s.r.l.
15.8. SARSTEDT AG & Co. KG
15.9. Greiner Holding AG
15.10. Haemonetics Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL BLOOD COLLECTION MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Collection Site (Venous {Needles and Syringes, Blood collection Tubes, Blood Bags, Others}, Capillary {Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices, Others})
5.2.2. By Application (Diagnostics, Treatment)
5.2.3. By Method (Manual, Automated)
5.2.4. By End-use (Hospitals, Blood Banks, Others)
5.2.5. By Company (2023)
5.2.6. By Region
5.3. Market Map
6. NORTH AMERICA BLOOD COLLECTION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Collection Site
6.2.2. By Application
6.2.3. By Method
6.2.4. By End-use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Blood Collection Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Collection Site
6.3.1.2.2. By Application
6.3.1.2.3. By Method
6.3.1.2.4. By End Use
6.3.2. Mexico Blood Collection Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Collection Site
6.3.2.2.2. By Application
6.3.2.2.3. By Method
6.3.2.2.4. By End Use
6.3.3. Canada Blood Collection Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Collection Site
6.3.3.2.2. By Application
6.3.3.2.3. By Method
6.3.3.2.4. By End Use
7. EUROPE BLOOD COLLECTION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Collection Site
7.2.2. By Application
7.2.3. By Method
7.2.4. By End-use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Blood Collection Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Collection Site
7.3.1.2.2. By Application
7.3.1.2.3. By Method
7.3.1.2.4. By End Use
7.3.2. Germany Blood Collection Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Collection Site
7.3.2.2.2. By Application
7.3.2.2.3. By Method
7.3.2.2.4. By End Use
7.3.3. United Kingdom Blood Collection Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Collection Site
7.3.3.2.2. By Application
7.3.3.2.3. By Method
7.3.3.2.4. By End Use
7.3.4. Italy Blood Collection Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Collection Site
7.3.4.2.2. By Application
7.3.4.2.3. By Method
7.3.4.2.4. By End Use
7.3.5. Spain Blood Collection Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Collection Site
7.3.5.2.2. By Application
7.3.5.2.3. By Method
7.3.5.2.4. By End Use
8. ASIA-PACIFIC BLOOD COLLECTION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Collection Site
8.2.2. By Application
8.2.3. By Method
8.2.4. By End-use
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Blood Collection Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Collection Site
8.3.1.2.2. By Application
8.3.1.2.3. By Method
8.3.1.2.4. By End Use
8.3.2. India Blood Collection Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Collection Site
8.3.2.2.2. By Application
8.3.2.2.3. By Method
8.3.2.2.4. By End Use
8.3.3. South Korea Blood Collection Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Collection Site
8.3.3.2.2. By Application
8.3.3.2.3. By Method
8.3.3.2.4. By End Use
8.3.4. Japan Blood Collection Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Collection Site
8.3.4.2.2. By Application
8.3.4.2.3. By Method
8.3.4.2.4. By End Use
8.3.5. Australia Blood Collection Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Collection Site
8.3.5.2.2. By Application
8.3.5.2.3. By Method
8.3.5.2.4. By End Use
9. SOUTH AMERICA BLOOD COLLECTION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Collection Market Site
9.2.2. By Application
9.2.3. By Method
9.2.4. By End-use
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Blood Collection Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Collection Site
9.3.1.2.2. By Application
9.3.1.2.3. By Method
9.3.1.2.4. By End Use
9.3.2. Argentina Blood Collection Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Collection Site
9.3.2.2.2. By Application
9.3.2.2.3. By Method
9.3.2.2.4. By End Use
9.3.3. Colombia Blood Collection Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Collection Site
9.3.3.2.2. By Application
9.3.3.2.3. By Method
9.3.3.2.4. By End Use
10. MIDDLE EAST AND AFRICA BLOOD COLLECTION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Collection Market Site
10.2.2. By Application
10.2.3. By Method
10.2.4. By End-use
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Blood Collection Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Collection Site
10.3.1.2.2. By Application
10.3.1.2.3. By Method
10.3.1.2.4. By End Use
10.3.2. Saudi Arabia Blood Collection Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Collection Site
10.3.2.2.2. By Application
10.3.2.2.3. By Method
10.3.2.2.4. By End Use
10.3.3. UAE Blood Collection Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Collection Site
10.3.3.2.2. By Application
10.3.3.2.3. By Method
10.3.3.2.4. By End Use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. COMPETITIVE LANDSCAPE
15.1. NIPRO Medical Corporation
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Abbott Laboratories Inc.
15.3. Becton, Dickinson and Company
15.4. Terumo Corporation
15.5. Qiagen N.V
15.6. Medtronic plc
15.7. FL Medical s.r.l.
15.8. SARSTEDT AG & Co. KG
15.9. Greiner Holding AG
15.10. Haemonetics Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
